Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

ADVL1411 Temozolomide in Children with Refractory or Recurrent Malignancies

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Description:

This study being completed in collaboration with Cincinnati Children's Hospital. For complete information please visit clinicaltrials.gov

Study Status:

Closed

IRB Study ID:

141003

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...